ArticleExpert opinion on therapeutic targets2025
The molecular role of RE1 silencing transcription factor in uterine diseases: is there potential for targeted therapeutic development?
Warren B Nothnick et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.